BIMI International Medical (FRA:63N) Debt-to-Equity : 0.51 (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is BIMI International Medical Debt-to-Equity?

BIMI International Medical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was €1.87 Mil. BIMI International Medical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was €2.32 Mil. BIMI International Medical's Total Stockholders Equity for the quarter that ended in Sep. 2023 was €8.16 Mil. BIMI International Medical's debt to equity for the quarter that ended in Sep. 2023 was 0.51.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for BIMI International Medical's Debt-to-Equity or its related term are showing as below:

FRA:63N' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.27 Max: 1.35
Current: 0.51

During the past 13 years, the highest Debt-to-Equity Ratio of BIMI International Medical was 1.35. The lowest was 0.01. And the median was 0.27.

FRA:63N's Debt-to-Equity is ranked worse than
51.47% of 546 companies
in the Healthcare Providers & Services industry
Industry Median: 0.48 vs FRA:63N: 0.51

BIMI International Medical Debt-to-Equity Historical Data

The historical data trend for BIMI International Medical's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BIMI International Medical Debt-to-Equity Chart

BIMI International Medical Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Debt-to-Equity

Get a 7-Day Free Trial

0.01

0.30

0.78

1.35

BIMI International Medical Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Debt-to-Equity	Get a 7-Day Free Trial															1.29	1.35	0.68	0.41	0.51

Competitive Comparison of BIMI International Medical's Debt-to-Equity

For the Pharmaceutical Retailers subindustry, BIMI International Medical's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BIMI International Medical's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, BIMI International Medical's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where BIMI International Medical's Debt-to-Equity falls into.

BIMI International Medical Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

BIMI International Medical's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.422	+	2.728)	/	3.821
	=	1.35

BIMI International Medical's Debt to Equity Ratio for the quarter that ended in Sep. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.873	+	2.315)	/	8.158
	=	0.51

BIMI International Medical (FRA:63N) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

BIMI International Medical Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of BIMI International Medical's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

BIMI International Medical (FRA:63N) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BIMI International Medical Inc (FRA:63N) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

BIMI:USA

Address

Chongqing Corporation Avenue, 9th Floor, Building 2, Yuzhong District, Chongqing, CHN, 400010

Website

https://www.usbimi.com

BIMI International Medical Inc is a healthcare product and provider, offering a broad range of healthcare products and related services and operates private hospitals in China. The company is engaged in four business segments, Pharmaceuticals wholesale, Medical devices wholesale, Medical services, and Pharmacy retail. It generates maximum revenue from the pharmaceuticals wholesale segment. It mainly sources its products from large state-owned pharmaceutical manufacturers and wholesalers and mid-sized or small private pharmaceutical manufacturers and wholesalers. The Company's revenues were generated in the PRC.

BIMI International Medical (FRA:63N) Headlines

No Headlines